ArticleOphthalmology and therapy2025

Economic Benefit of Aflibercept 8 mg Versus Faricimab for Neovascular Age-Related Macular Degeneration or Diabetic Macular Edema in the US.

Andreas Kuznik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.